Clear Point Advisors »

Arrowhead Pharmaceuticals shares owned by Clear Point Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Clear Point Advisors from 13F filings

Historical chart of Clear Point Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Clear Point Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Clear Point Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $48k 1.9k 25.99
2024-03-31 $53k 1.9k 28.60
2023-12-31 $57k 1.9k 30.60

More positions owned by Clear Point Advisors

Schwab Us Large Cap Growth Etf Uie (SCHG)
Doubleline Shiller Cape Us Equts Etf Uie (CAPE)
Invsc Qqq Trust Srs 1 Etf Iv Uie (QQQ)
Schwab Us Broad Market Etf Uie (SCHB)
Pimco Enhanced Shrt Maturty Actv Etf Uie (MINT)
Spdr S&p 500 Etf Uie (SPY)
Innovator Us Equity Power Buffer Etf Uie (PJUN)
Spdr S&p Midcap 400 Etf Uie (MDY)
Apple (AAPL)
First Trust Enhanced Short Mtrty Etf Uie (FTSM)
Wisdomtree Floating Ratetreasry Etf Uie (USFR)
Ft Vest Us Equity Bufferetf Uie (FMAY)
Graniteshares Gold Etf Uie (BAR)
Schwab Us Large Cap Etf Uie (SCHX)
Jpmorgan Ultra Shrt Muncipl Incm Etf Uie (JMST)

View all positions for Clear Point Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Artal Group
Slate Path Capital
Geode Capital Management
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Morgan Stanley
Goldman Sachs Group
Bank of New York Mellon
Citadel Advisors
Charles Schwab Investment Management
Rokos Capital Management
Aquilo Capital Management

View all funds holding Arrowhead Pharmaceuticals